AnnJi Pharmaceutical Co., Ltd. (TPEX:7754)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.90
-2.40 (-3.79%)
Sep 8, 2026, 12:50 PM CST

AnnJi Pharmaceutical Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-405.97-357.87-353.99-329.22-236.65-198.63
Depreciation & Amortization
44.0344.244.337.7440.0541.51
Other Amortization
1.020.960.650.550.380.12
Loss (Gain) From Sale of Assets
---0.09-0.2-0.34-
Loss (Gain) From Sale of Investments
-0.974.5429.42--
Stock-Based Compensation
16.418.0846.7848.26.663.02
Other Operating Activities
12.52-1.99-0.4738.92--0.01
Change in Accounts Receivable
-0.010.01-0.150.09-0.09-
Change in Inventory
6.889.31-27.42---
Change in Accounts Payable
--0.120.12-15.664.39
Change in Unearned Revenue
--6.3866.6589.561.6-
Change in Other Net Operating Assets
-9.76-47.4633.0617.73-16.759.21
Operating Cash Flow
-334.88-350.29-186.01-67.2-189.49-140.39
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.25-2.91-9.95-12.04-1.58-3.23
Sale of Property, Plant & Equipment
--0.090.260.36-
Sale (Purchase) of Intangibles
-0.34-0.82-0.56-0.35-0.42-0.52
Investment in Securities
7474198-274-100
Other Investing Activities
-0.03-0.030.74-1.9-0.39
Investing Cash Flow
71.3870.23188.31-288.02-1.6596.65

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Repaid
------17.08
Long-Term Debt Repaid
--5.98-5.95--2.79-3.25
Lease Payments
-6.07-5.98-5.95--2.79-3.25
Total Debt Repaid
-6.07-5.98-5.95--2.79-20.33
Net Debt Issued (Repaid)
-6.07-5.98-5.95--2.79-20.33
Issuance of Common Stock
298.283.4633.02685.1870364.5
Other Financing Activities
--1.82--0.16-
Financing Cash Flow
292.22-2.5228.89685.1867.05344.17

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
----0.57-0.57
Net Cash Flow
28.71-282.5731.19329.96-123.51299.85

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-337.13-353.2-195.97-79.23-191.07-143.62
Free Cash Flow Growth
------
Free Cash Flow Margin
-35154.12%-4676.88%-203.18%-55.20%-11750.92%-10008.22%
Free Cash Flow Per Share
-3.52-3.76-2.11-1.02-2.91-3.18
Levered Free Cash Flow
-156.9-353.92-78.5793.18-104.84-
Unlevered Free Cash Flow
-155.95-352.92-77.4693.47-104.82-
Free Cash Flow After Leases
-343.2-359.18-201.92-79.23-193.86-146.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.511.62.25-0.030.15
Cash Income Tax Paid
----0.011.59-0.01
Change in Working Capital
-2.89-44.6372.26107.380.4213.6